Nice to see that you have changed your sentiment
The FDA process to approval is the first stage of getting our products to market . The next would be to come to a agreement to the price. To the uneducated, this appears to be the hardest part. $US 100 thousand or more per treatment is a lot of money . Perhaps a new technology deserves a new approach . A guarantee of effective treatment by MSB would solve many problems .
None responders would get a full refund.
FDA would also like that commitment as it would give them confidence that the products natural variations and delivery systems would not only be closely monitored but may in the future be adjusted to become better. Do you think such a system would work?
MSB short selling data - 25th.Jan.2019, page-72
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |